Showing Results for: ibrutinib

From The blog

image title
Treatment

FDA Expands Approved Use of Leukemia Drug Imbruvica

By John Lugo

Based on positive results from the RESONATE clinical trial, the U.S. Food and Drug Administration has approved Imbruvica (ibrutinib) for treatment in chronic lymphocytic leukemia (CLL) patients who …

Not what you were looking for? Let's try this again: